Affinity Asset Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-190,000
| Closed | -$12.9M | – | 78 |
|
|
2022
Q3 | $12.9M | Buy |
+190,000
| New | +$12.9M | 3.61% | 3 |
|
|
2022
Q2 | – | Sell |
-70,000
| Closed | -$2.43M | – | 67 |
|
|
2022
Q1 | $2.43M | Buy |
+70,000
| New | +$2.43M | 0.39% | 32 |
|
|
2021
Q4 | – | Sell |
-75,000
| Closed | -$1.91M | – | 81 |
|
|
2021
Q3 | $1.91M | Buy |
75,000
+55,000
| +275% | +$1.4M | 0.48% | 37 |
|
|
2021
Q2 | $700K | Hold |
20,000
| – | – | 0.25% | 54 |
|
|
2021
Q1 | $815K | Sell |
20,000
-30,000
| -60% | -$1.22M | 0.28% | 42 |
|
|
2020
Q4 | $2.17M | Buy |
+50,000
| New | +$2.17M | 1.15% | 24 |
|